drugset / Trial / NCT00138697
Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The kinetics, efficacy and safety of a liquid intravenous immunoglobulin product, IVIG-L, were studied in patients with hypogammaglobulinemia, who are regularly treated with intravenous immunoglobulin substitution therapy.
Timeline
- Start
- 2001-05
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IVIG-L | Protein / enzyme biologic | — | Intravenous |